The expression of NGFr and PGP 9.5 in leprosy reactional cutaneous lesions: An assessment of the nerve fiber status using immunostaining

Arquivos de Neuro-Psiquiatria

Volumn 61, Issue 2 B, 2003, Pages 346-352

  Antunes, Sérgio Luiz Gomes ^a,b   Liang, Yong ^c   Da Costa Neri, José Augusto ^a   Haak Frendscho, Mary ^d   Johansson, Olle ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Iguaçu University UNIG   (Brazil)

^c KAROLINSKA INSTITUTE   (Sweden)

^d PROMEGA CORPORATION   (United States)

Author keywords

Leprosy; Nerve growth factor receptor; Neurotrophic factor; Protein gene product 9.5

Indexed keywords

GENE PRODUCT; NERVE GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CRYOPRESERVATION; ERYTHEMA NODOSUM LEPROSUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEPROSY; MALE; MYELIN SHEATH; NERVE FIBER; NEUROLOGIC EXAMINATION; PROTEIN EXPRESSION; REMISSION; SKIN BIOPSY; SKIN DEFECT; SKIN NERVE; STATISTICAL ANALYSIS;

EID: 0038504515     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2003000300005     Document Type: Article

References (28)

1. Bryceson A, Pfaltzgraff RE. Immunological complications: reactions. In Leprosy. Medicine in the tropics. Edingburgh: Churchill Livingstone, 1990:115-126.
2. Sehgal VN, Srivastava G, Sundharam JA. Immunology of reactions in leprosy: current status. Int J Dermatol 1988;27:157-162.
3. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1992;254:277-282.
4. Sarno EN, Grau GE, Vieira LMM, Nery JA. Serum levels of tumor necrosis factor-alpha and interleukin-1b during leprosy reactional states. Clin Exp Immunol 1991;84:103-108.
5. Lienhardt C, Fine PEM. Type I reaction, neuritis, and disability in leprosy. Lepr Rev 1994;65:9-33.
6. Uyemura K, Band H, Ohmen J, Brenner MB, Rea TH, Modlin RL. γδ T cells in leprosy lesions. Curr Top Microbiol Immunol 1991;173:203-207.
7. Moraes MO, Sarno EN, Almeida AS, et al. Cytokine m RNA expression in leprosy: a possible role for interferon-γ and interleukin-12 in reactions (RR and ENL). Scand J Immunol 1999;50:541-549.
8. Thacker AK, Chandra S, Mukhija RD, Sarkari NB. Electro-physiological evaluation of nerves during reactions in leprosy. J Neurol 1996;243:530-535.
9. Stoll G, Müller HW. Nerve injury, axonal regeneration and neural regeneration: basic insights. Brain Pathol 1999;9:313-325.
10. Zoghbi HY, Gage FH, Choi DW. Neurobiology of disease. Curr Opinion Neurobiol 2000;10:655-660.
11. Meakin SO, Shooter EM The nerve growth factor family of receptors. Trends Neurosci 1992;15:323-331.
12. Anton ES, Weskamp G, Reichardt LF, Matthew WD. Nerve growth factor and its low affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA 1994;91:2795-2799.
13. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989;337:362-364.
14. Frade JM, Rodriguez-Tebar, Barde Y-A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 1996;383:166-168.
15. Hermann JL, Menter DG, Hamada J, Marchetti D, Nakajima M, Nicolson GL. Mediation of NGF stimulated extracellular matrix invasion by the human melanoma low affinity p75 neurotrophin receptor: melanoma p75 functions independently on trk A. Mol Biol Cell 1993;4:1205-1216.
16. Marlini R. Expression and functional roles of neural surface molecules and extracellular matrix components during developent and regeneration of peripheral nerves. J Neurocytol 1994;23:1-28.
17. Anand P, Pandya S, Ladiwala U, Singhal B, Sinicropi DV, Williams-Chestnut RE. Depletion of nerve growth factor in leprosy. Lancet 1994;344:129-130
18. Facer P, Mann D, Mathur R, et al. Do nerve growth factor-related mechanisms contribute to loss of cutaneous nociception in leprosy? Pain 2000;85:231-238.
19. Facer P, Mathur R, Pandya SS, Ladiwala U, Singhal BS, Anand P. Correlation of quantitative tests of nerve and target organ dysfunction with skin immunohistology in leprosy. Brain 1998;121:2239-2247.
20. Antunes SLGA, Sarno EN, Holmqvist G, Johansson O. A comparison of the expression of NGFr with PGP 9.5 and NSE in the cutaneous lesions of early leprosy patients using immunohistochemistry. Int J Lepr 1997;65:357-365.
21. Aquilonius SM, Ashmark H, Ebendal T, Gillberg PG. No re-expression of high affinity nerve growth factor binding sites in spinal motor neurons in amyotrophic lateral sclerosis. Eur Neurol 1992;32:216-218.
22. Johansson O, Hilliges M, Ståhle-Bäckdahl M. Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett 1989;99:281-286.
23. Karanth SS, Springall DR, Lucas S, et al. Changes in nerves and neuropeptides in skin from 100 leprosy patients investigated by immunocytochemistry. J Pathol 1989;157:15-26
24. Shetty VP, Antia NH. Pathology of nerve damage in leprosy. In Shetty VP, Antia NH. The peripheral nerve in leprosy and other neuropathies. Calcutta Oxford Univ Press, 1997;79-138.
25. Antunes SLG, Sarno EN. Ultrastructural study of dermal nerves in the cutaneous lesions of early leprosy patients. Hansenologia Internationalis 1997;21:14-21.
26. Miko TL, Gschmeissner SE, le Maitre C, Kinfu Y, Kazen R, Pereira JH. Regeneration at the predilective damage sites of nerve trunks in treated leprosy. Lepr Rev 1993;64:330-337
27. Liang Y, Johansson O. Light and electron microscopic demonstration of the p75 nerve growth factor receptor in normal human cutaneous nerve fibers: new vistas. J Invest Dermatol 1998;111:114-118.
28. Liang Y, Marcusson JA, Johansson O. Light and electron microscopic immunohistochemical observations of p75 nerve growth factor receptor-immunoreactive dermal nerves in prurigo nodularis. Arch Dermatol Res 1999;291:14-21.